Results 11 to 20 of about 32,411 (197)

Effect of Educational Guidelines Implementation on Nurses' Performance Regarding Thrombolytic Therapy Management among Patients with Acute Myocardial Infarction [PDF]

open access: yesEgyptian Journal of Health Care
A well-established treatment for acute myocardial infarction, thrombolytic therapy has time-dependent advantages. When patients are admitted to the hospital with a suspected myocardial infarction, nurses are frequently the first medical personnel to ...
Elhaga Ibrahim Eldesouky Mohamed   +4 more
doaj   +1 more source

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION

open access: yesРациональная фармакотерапия в кардиологии, 2015
History of thrombolytic therapy is shortly reflected, main trials of various thrombolytics in acute ST-segment elevation myocardial infarction (STEMI) are analyzed. Perspectives of modern thrombolytic therapy in patients with STEMI are discussed.
P. G. Kesov   +3 more
doaj   +3 more sources

Aspect of Thrombolytic Therapy: A Review

open access: yesThe Scientific World Journal, 2014
Thrombolytic therapy, also known as clot busting drug, is a breakthrough treatment which has saved untold lives. It has been used in the clinical area to treat venous and arterial thromboembolic complaints which are a foremost cause of death.
Md. Ramjan Ali   +6 more
doaj   +1 more source

Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke

open access: yesChinese Medical Journal, 2017
Objective: To provide a comprehensive and latest overview of susceptibility-weighted imaging (SWI) in the application of thrombolysis in acute ischemic stroke, and to update the decision-making effect and clinical value of SWI on identifying stroke ...
Lin Li   +6 more
doaj   +1 more source

Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives Acute cerebral ischemia is characterized by several pathological processes evolving during time, which contribute to the final tissue damage. Secondary processes, such as prolonged inflammatory response, impaired mitochondrial function and oxidative stress, are responsible for the progression of brain injury to the peri‐infarct area,
Fioravante Capone   +8 more
wiley   +1 more source

Utilization of emergency medical service increases chance of thrombolytic therapy in patients with acute ischemic stroke

open access: yesJournal of the Formosan Medical Association, 2014
To determine whether utilization of emergency medical service (EMS) can increase use and expedite delivery of the thrombolytic therapy in acute ischemic stroke patients. Methods: We analyzed consecutive patients presenting to the emergency department (ED)
Ming-Ju Hsieh   +8 more
doaj   +1 more source

Safety and Effectiveness of Thrombolytic Therapy Compared with Standard Anticoagulation in Subjects with Submassive Pulmonary Embolism

open access: yesErciyes Medical Journal, 2019
Objective: Thrombolytic and anticoagulation therapy modalities are the possible treatment for submassive pulmonary embolism (PE). However, the indications are still the subject of debate.
Pınar Çimen   +5 more
doaj   +1 more source

Thrombolytic therapy delay is independent predictor of mortality in acute pulmonary embolism at emergency service

open access: yesKaohsiung Journal of Medical Sciences, 2016
Acute pulmonary embolism (PE) carries a high risk of morbidity and mortality. Delays in diagnosis or therapy may result in sudden, fatal deterioration; therefore, rapid diagnosis and an appropriate therapeutic approach are needed. We aimed to investigate
İnan Beydilli   +7 more
doaj   +1 more source

Orolingual angioedema as a complication of systemic thrombolytic therapy with recombinant tissue plasminogen activator

open access: yesВестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2023
Orolingual angioedema is a rare, but extremely dangerous complication of systemic thrombolytic therapy with recombinant tissue plasminogen activator, the incidence of which reaches 2.2-5.1 %.
E. A. Kovaleva   +6 more
doaj   +1 more source

Thrombolytic therapy

open access: yesHematology/Oncology Clinics of North America, 2002
The therapeutic use of thrombolytic agents is the natural result of the increasing understanding of the pathophysiologic mechanisms underlying normal and deranged thrombosis and fibrinolysis. Plasminogen activators capable of increasing the production of plasmin exhibit considerable efficacy in the treatment of a variety of arterial and venous ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy